Pfizer’s corona vaccine begins trial on pregnant women-Read

WASHINGTON (Reuters) – US pharmaceutical company Pfizer and German technology company BioNTech have begun trials of the corona vaccine in pregnant women.

According to the international news agency, the first trial of pregnant women of Corona vaccine in the world has been started by Pfizer and BioNTech. The trials will take place in the United States, Canada, Argentina, Brazil, Chile, Mozambique, South Africa, the United Kingdom and Spain.

The Pfizer Corona vaccine trial involved 4,000 pregnant women over the age of 18 who are 24 to 34 weeks pregnant, while the women in the placebo group were vaccinated after giving birth. Will be done soon.

The most important thing to consider during a trial on pregnant women is whether the protective corona vaccine transmits antibodies in pregnant women to children.

In this regard, Chief Medical Officer Dr. Ozlam Torsi said that the next step of the corona vaccine trial will be to assess the effects on pregnant women so that in the future pregnant women can be protected from the deadly virus.

Dr. William Gruber, senior vice president of clinical research and development at Pfizer, said in a statement that the results of the trial were “very promising”.

Pfizer plans to try the corona vaccine in children after pregnant women, but Oxford University and AstraZeneca have already started trials in children, but Pfizer has started the first trials in pregnant women.

Experts warn that coronary heart disease in pregnant women increases the risk to a dangerous level, which can lead to maternal and child deaths. The US National Institutes of Health also called on pharmaceutical companies to try pregnant women.


Leave a Comment

Your email address will not be published. Required fields are marked *